Gennex Laboratories Limited (BOM:531739)
8.92
-0.16 (-1.76%)
At close: Jul 27, 2026
Gennex Laboratories Revenue
In the fiscal year ending March 31, 2026, Gennex Laboratories had annual revenue of 1.73B INR with 25.26% growth. Gennex Laboratories had revenue of 609.55M in the quarter ending March 31, 2026, with 51.16% growth.
Revenue
1.73B
Revenue Growth
+25.26%
P/S Ratio
1.25
Revenue / Employee
15.02M
Employees
115
Market Cap
2.17B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.73B | 348.38M | 25.26% |
| Mar 31, 2025 | 1.38B | 511.89M | 59.03% |
| Mar 31, 2024 | 867.14M | 211.11M | 32.18% |
| Mar 31, 2023 | 656.03M | 43.89M | 7.17% |
| Mar 31, 2022 | 612.14M | 15.65M | 2.62% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ambalal Sarabhai Enterprises | 2.03B |
| Sat Kartar Life | 2.01B |
| Everest Organics | 1.97B |
| Astonea Labs | 1.48B |
| Kerala Ayurveda | 1.31B |
| Oxygenta Pharmaceutical | 1.13B |
| Accretion Pharmaceuticals | 898.18M |
| Coral Laboratories | 859.00M |